Patents by Inventor Jonathan Wendell Tetreault

Jonathan Wendell Tetreault has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-IL-17 antibodies
    Patent number: 8110191
    Abstract: Anti-IL-17 antibodies are identified that are characterized as having a high affinity and slow off rate for human IL-17. The antibodies of the invention may be chimeric, humanized or fully human antibodies, immunoconjugates of the antibodies or antigen-binding fragments thereof. The antibodies of the invention are useful in particular for treating autoimmune, inflammatory, cell proliferative and developmental disorders.
    Type: Grant
    Filed: October 21, 2010
    Date of Patent: February 7, 2012
    Assignee: Eli Lilly and Company
    Inventors: Barrett Allan, Chi-Kin Chow, Ling Liu, Jirong Lu, Jonathan Wendell Tetreault, Ying Tang
  • ANTI-IL-17 ANTIBODIES
    Publication number: 20110027290
    Abstract: Anti-IL-17 antibodies are identified that are characterized as having a high affinity and slow off rate for human IL-17. The antibodies of the invention may be chimeric, humanized or fully human antibodies, immunoconjugates of the antibodies or antigen-binding fragments thereof. The antibodies of the invention are useful in particular for treating autoimmune, inflammatory, cell proliferative and developmental disorders.
    Type: Application
    Filed: October 21, 2010
    Publication date: February 3, 2011
    Applicant: ELI LILLY AND COMPANY
    Inventors: Barrett Allan, Chi-Kin Chow, Ling Liu, Jirong Lu, Jonathan Wendell Tetreault
  • Anti-IL-17 antibodies
    Patent number: 7838638
    Abstract: Anti-IL-17 antibodies are identified that are characterized as having a high affinity and slow off rate for human IL-17. The antibodies of the invention may be chimeric, humanized or fully human antibodies, immunoconjugates of the antibodies or antigen-binding fragments thereof. The antibodies of the invention are useful in particular for treating autoimmune, inflammatory, cell proliferative and developmental disorders.
    Type: Grant
    Filed: December 5, 2006
    Date of Patent: November 23, 2010
    Assignee: Eli Lilly and Company
    Inventors: Barrett Allan, Chi-Kin Chow, Ling Liu, Jirong Lu, Jonathan Wendell Tetreault
  • Anti-IL-17 Antibodies
    Publication number: 20080269467
    Abstract: Anti-IL-17 antibodies are identified that are characterized as having a high affinity and slow off rate for human IL-17. The antibodies of the invention may be chimeric, humanized or fully human antibodies, immunoconjugates of the antibodies or antigen-binding fragments thereof. The antibodies of the invention are useful in particular for treating autoimmune, inflammatory, cell proliferative and developmental disorders.
    Type: Application
    Filed: December 5, 2006
    Publication date: October 30, 2008
    Inventors: Barrett Allan, Chi-Kin Chow, Lihua Huang, Ling Liu, Jirong Lu, Kingman Ng, Jonathan Wendell Tetreault, Andrew Gordon Werner